<--- Back to Details
First PageDocument Content
Security / Biometrics / Identification / Surveillance / Electronic signature / Title 21 CFR Part 11 / Validation / X Window System / Food and Drug Administration / Pharmaceutical industry / Pharmaceutical sciences / Software
Date: 2002-08-08 09:45:54
Security
Biometrics
Identification
Surveillance
Electronic signature
Title 21 CFR Part 11
Validation
X Window System
Food and Drug Administration
Pharmaceutical industry
Pharmaceutical sciences
Software

Memo of Meeting; Vector Intelligence[removed]

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 39,41 KB

Share Document on Facebook

Similar Documents

Code of Federal Regulations / Food and Drug Administration / Technology / Pharmaceutical industry / Pharmaceuticals policy / Title 21 CFR Part 11 / United States administrative law / Section 508 Amendment to the Rehabilitation Act / MyRIO / Health care / Pharmacology

508 Checklist FINAL REVISED10-8-14.xls

DocID: 1r6Jh - View Document

Code of Federal Regulations / Food and Drug Administration / Avionics / Technology / United States administrative law / Law / Unmanned aerial vehicle / Wireless / Drug test / Title 21 CFR Part 11 / Health care

Civil Aviation Safety Regulations 1998 Statutory Rules 1998 No. 237 as amended made under the Civil Aviation Act 1988

DocID: 1qR0c - View Document

United States administrative law / Government / Bureau of Indian Affairs / BIA / Federal Register / Title 21 CFR Part 11 / Law / Health care

Federal Register / Vol. 81, NoMonday, March 21, Rules and Regulations List of Subjects in 21 CFR Part 14

DocID: 1qQyE - View Document

Health / Smoking / Food and Drug Administration / Tobacco control / Food law / Pharmaceuticals policy / Code of Federal Regulations / Federal Food /  Drug /  and Cosmetic Act / Dissolvable tobacco / Compounding / Title 21 of the Code of Federal Regulations / Title 21 CFR Part 11

PDF Document

DocID: 1qKzO - View Document

Pharmaceutical industry / Pharmacology / Pharmaceutical sciences / Economy / Pharmaceuticals policy / Clinical data management / Code of Federal Regulations / Food and Drug Administration / Title 21 CFR Part 11 / Good manufacturing practice / Validation / Title 21 of the Code of Federal Regulations

Data Integrity and Compliance With CGMP Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

DocID: 1q6Px - View Document